Literature DB >> 24993040

Prostate imaging--the future is now: current concepts and future potentials.

Felix K-H Chun1, Thomas R W Herrmann.   

Abstract

Mesh：

Year:  2014        PMID： 24993040     DOI： 10.1007/s00345-014-1354-x

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  16 in total

1.  Re: Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy: A. R. Rastinehad, B. Turkbey, S. S. Salami, O. Yaskiv, A. K. George, M. Fakhoury, K. Beecher, M. A. Vira, L. R. Kavoussi, D. N. Siegel, R. Villani and E. Ben-Levi. J Urol 2014; 191: 1749-1754.

Authors:  Madhusudan Patodia; Apul Goel; Manoj Kumar
Journal:  J Urol       Date:  2014-09-04       Impact factor: 7.450

Review 2.  Overdiagnosis and overtreatment of prostate cancer.

Authors:  Stacy Loeb; Marc A Bjurlin; Joseph Nicholson; Teuvo L Tammela; David F Penson; H Ballentine Carter; Peter Carroll; Ruth Etzioni
Journal:  Eur Urol       Date:  2014-01-09       Impact factor: 20.096

Review 3.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review.

Authors:  Caroline M Moore; Nicola L Robertson; Nasr Arsanious; Thomas Middleton; Arnauld Villers; Laurence Klotz; Samir S Taneja; Mark Emberton
Journal:  Eur Urol       Date:  2012-06-13       Impact factor: 20.096

Review 4.  Overdetection in screening for prostate cancer.

Authors:  Jonas Hugosson; Sigrid Carlsson
Journal:  Curr Opin Urol       Date:  2014-05       Impact factor: 2.309

5.  Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.

Authors:  Simpa S Salami; Manish A Vira; Baris Turkbey; Mathew Fakhoury; Oksana Yaskiv; Robert Villani; Eran Ben-Levi; Ardeshir R Rastinehad
Journal:  Cancer       Date:  2014-06-10       Impact factor: 6.860

Review 6.  Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?

Authors:  Hashim Uddin Ahmed; Manit Arya; Alex Freeman; Mark Emberton
Journal:  Lancet Oncol       Date:  2012-11       Impact factor: 41.316

7.  Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.

Authors:  Felix K-H Chun; Alexander Haese; Sascha A Ahyai; Jochen Walz; Nazareno Suardi; Umberto Capitanio; Markus Graefen; Andreas Erbersdobler; Hartwig Huland; Pierre I Karakiewicz
Journal:  Cancer       Date:  2008-08-15       Impact factor: 6.860

8.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

9.  Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.

Authors:  Hashim U Ahmed; Richard G Hindley; Louise Dickinson; Alex Freeman; Alex P Kirkham; Mahua Sahu; Rebecca Scott; Clare Allen; Jan Van der Meulen; Mark Emberton
Journal:  Lancet Oncol       Date:  2012-04-17       Impact factor: 41.316

10.  A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.

Authors:  Eric A Klein; Matthew R Cooperberg; Cristina Magi-Galluzzi; Jeffry P Simko; Sara M Falzarano; Tara Maddala; June M Chan; Jianbo Li; Janet E Cowan; Athanasios C Tsiatis; Diana B Cherbavaz; Robert J Pelham; Imelda Tenggara-Hunter; Frederick L Baehner; Dejan Knezevic; Phillip G Febbo; Steven Shak; Michael W Kattan; Mark Lee; Peter R Carroll
Journal:  Eur Urol       Date:  2014-05-16       Impact factor: 20.096
View more
  2 in total

1.  Evaluation of the 'Prostate Interdisciplinary Communication and Mapping Algorithm for Biopsy and Pathology' (PIC-MABP).

Authors:  Daniel Junker; Thomas R W Herrmann; Markus Bader; Jasmin Bektic; Gregor Henkel; Stephan Kruck; Markus Sandbichler; David Schilling; Georg Schäfer; Udo Nagele
Journal:  World J Urol       Date:  2015-07-01       Impact factor: 4.226

2.  Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.

Authors:  Susanne Tewes; Katja Hueper; Dagmar Hartung; Florian Imkamp; Thomas R W Herrmann; Juergen Weidemann; Stefan Renckly; Markus A Kuczyk; Frank Wacker; Inga Peters
Journal:  World J Urol       Date:  2015-03-14       Impact factor: 4.226
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.